Activation of T-cells, and in particular CD8+ T-cells, is an important factor in combating EBV-infection as shown by increased risk of EBV-associated pathologies in immunodeficiencies characterized by T-cell dysfunction (18). This evidence concerns the gene CD8A and immune system disorder.